Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Coverage

Latest content

Juha Kinnunen

Analyst

Juha Kinnunen portrait

Coverage

Detection TechnologyFondiaFortumAspocomp GroupBittiumRevenio GroupTalenomOptomed

Latest content

ShowingAll content types

Revenio: New iCare IC1000 strengthens core business competitiveness

Analyst Comment 10.09.2026 klo 11.58 by Juha Kinnunen
Revenio Group

Revenio Q2'26: Vision to become clearer toward the end of the year

Research 09.09.2026 klo 11.55 by Juha Kinnunen
Revenio Group

Revenio Q2'26 preview: First step for new vision

Research 31.08.2026 klo 10.25 by Juha Kinnunen
Revenio Group

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account

Revenio: iCare's AI partner received green light from FDA

Analyst Comment 17.08.2026 klo 10.52 by Juha Kinnunen
Revenio Group

Talenom Q2'26: Unpleasant surprise in Spain clouded many positives

Research 14.08.2026 klo 18.37 by Juha Kinnunen
Talenom

Talenom Q2'26 preview: Spain boosts growth as new costs weigh on earnings

Analyst Comment 10.08.2026 klo 09.50 by Juha Kinnunen
Talenom

Revenio: iCare strengthens its foothold in the US screening market with EyeCheq partnership

Analyst Comment 07.08.2026 klo 08.57 by Juha Kinnunen
Revenio Group

Revenio: Visionix integration progresses as planned

Analyst Comment 03.08.2026 klo 09.04 by Juha Kinnunen
Revenio Group

Talenom extensive report: Finland stands firm, international turnaround is key

Extensive research 18.06.2026 klo 17.39 by Juha Kinnunen
Talenom

Revenio: Visionix acquisition completed slightly faster than expected

Analyst Comment 29.05.2026 klo 09.59 by Juha Kinnunen
Revenio Group